SCHEMBL27186331

SCHEMBL27186331

CC(=O)CC(=O)NC1CC(F)(F)C1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35
EPHX1 P07099 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33
EPHX2 P34913 1/20 0.33
HTT P42858 1/20 0.33
APLNR P35414 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
KDM1A O60341 2/20 0.31
MEN1 O00255 1/20 0.30
POLB P06746 1/20 0.30
MAPT P10636 1/20 0.30
RECQL P46063 1/20 0.30
USP2 O75604 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15138249 0.82 MTNR1A (0.40) GAAKMT2AKDM4EHTTAPLNR
SCHEMBL29223316 0.79 APLNR (0.34) GAAKMT2AKDM4EEPHX1GRIN1
SCHEMBL14904407 0.79 ATM (0.42) KDM4EEPHX2APLNR
SCHEMBL18343146 0.78 MTNR1A (0.40) GAAKMT2AEPHX1APLNRSMN1; SMN2
SCHEMBL22541823 0.78 APLNR (0.33) GAAKMT2AEPHX1GRIN1GRIN2B
SCHEMBL23384913 0.77 NPSR1 (0.58) KMT2AHTTNPSR1SMN1; SMN2MEN1
SCHEMBL9682135 0.77 GAA (0.58) GAAKMT2AKDM4EHTTMEN1
SCHEMBL18969609 0.77 HSD11B1 (0.38) GAAKMT2AGRIN1GRIN2BHTT
Hydrochloric Acid SCHEMBL30777466 0.77 ATM (0.41) KDM4EEPHX2APLNR
SCHEMBL16922982 0.76 SMN1; SMN2 (0.46) KMT2AEPHX1EPHX2NPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109887-A1 NOVEL SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AS SOS1 INHIBITORS VIVA STAR BIOSCIENCES (SUZHOU) CO., LTD. (CN) 2024-04-04 US disclosed
CN-117651701-A Novel substituted bicyclic aza heterocycles as SOS1 inhibitors 唯久生物技术(苏州)有限公司 2024-03-05 CN disclosed
WO-2022187266-A1 NOVEL SUBSTITUTED BICYCLI AZA-HETEROCYCLES AS SOS1 INHIBITORS VIVA STAR BIOSCIENCES (SUZHOU) CO., LTD. (CN) 2022-09-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109887-A1 NOVEL SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AS SOS1 INHIBITORS SOS1, SOS2, KSR1 GAA 2999/4885KMT2A 1656/4885KDM4E 1518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.